Fusen Pharmaceutical Co., Ltd.'s total assets for Q4 2024 were ¥1.24B, a decrease of -7.42% from the previous quarter. HK:1652 total liabilities were ¥869.80M for the fiscal quarter, a 6.30% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.